Pages that link to "Q44346815"
Jump to navigation
Jump to search
The following pages link to Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract (Q44346815):
Displaying 50 items.
- Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation (Q24644669) (← links)
- Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals (Q26745747) (← links)
- New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists (Q26748617) (← links)
- Opioid-induced constipation: advances and clinical guidance (Q26765571) (← links)
- Treatment of opioid-induced gut dysfunction (Q28284578) (← links)
- kappa -opioid receptor agonists modulate visceral nociception at a novel, peripheral site of action (Q28579996) (← links)
- Prospective observational pharmacogenetic study of side effects induced by intravenous morphine for postoperative analgesia. (Q33833573) (← links)
- Orphanin FQ/nociceptin: a novel neuromodulator of gastrointestinal function? (Q34040186) (← links)
- High levels of endorphin and related pathologies of veterinary concern. A review (Q34098400) (← links)
- Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors (Q34219916) (← links)
- Receptors and transmission in the brain-gut axis: potential for novel therapies. III. Mu-opioid receptors in the enteric nervous system (Q34283883) (← links)
- Olfaction under metabolic influences. (Q34290268) (← links)
- Overview and treatment of opioid-induced constipation (Q34352001) (← links)
- Morphine Induces μ Opioid Receptor Endocytosis in Guinea Pig Enteric Neurons Following Prolonged Receptor Activation (Q34551407) (← links)
- Neurochemical phenotype and function of endomorphin 2-immunopositive neurons in the myenteric plexus of the rat colon (Q34708533) (← links)
- Tapentadol extended release in the management of peripheral diabetic neuropathic pain (Q34982228) (← links)
- Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum (Q35048680) (← links)
- Opioid-induced bowel dysfunction: pathophysiology and potential new therapies (Q35091914) (← links)
- Opioid receptors and associated regulator of G protein signaling are involved in the cathartic colon of rats (Q35159547) (← links)
- Activation of μ opioid receptors modulates inflammation in acute experimental colitis. (Q35510067) (← links)
- Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review (Q35752958) (← links)
- Neurochemical features of endomorphin-2-containing neurons in the submucosal plexus of the rat colon (Q35778814) (← links)
- Opioids and the gut: pharmacology and current clinical experience. (Q35860904) (← links)
- RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives (Q35906057) (← links)
- Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR (Q36004099) (← links)
- Distribution and trafficking of the μ-opioid receptor in enteric neurons of the guinea pig. (Q36065514) (← links)
- Alvimopan, a selective peripherally acting mu-opioid antagonist (Q36078760) (← links)
- Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice (Q36227327) (← links)
- Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist (Q36382976) (← links)
- Ligand-induced μ opioid receptor internalization in enteric neurons following chronic treatment with the opiate fentanyl (Q36780862) (← links)
- Effects of methylnaltrexone on guinea pig gastrointestinal motility (Q36854395) (← links)
- Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives (Q37491434) (← links)
- Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy (Q37603682) (← links)
- Absence of Role of Dietary Protein Sensing in the Metabolic Benefits of Duodenal-Jejunal Bypass in the Mouse (Q37717414) (← links)
- Opioid-induced constipation: challenges and therapeutic opportunities (Q37846099) (← links)
- Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS. (Q38675489) (← links)
- Indications for Opioid Antagonists (Q38762441) (← links)
- Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits (Q38772298) (← links)
- Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications (Q38911748) (← links)
- Opioids and GI Motility-Friend or Foe? (Q38997203) (← links)
- Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline (Q39051851) (← links)
- YFa and analogs: investigation of opioid receptors in smooth muscle contraction (Q39164222) (← links)
- Methadone but not morphine inhibits lubiprostone-stimulated Cl- currents in T84 intestinal cells and recombinant human ClC-2, but not CFTR Cl- currents. (Q39291811) (← links)
- Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design (Q39522869) (← links)
- Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation (Q39750331) (← links)
- Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control (Q39887680) (← links)
- beta-Casomorphin-7 regulates the secretion and expression of gastrointestinal mucins through a mu-opioid pathway (Q40339679) (← links)
- GC-MS-based plasma metabolomic investigations of morphine dependent rats at different states of euphoria, tolerance and naloxone-precipitated withdrawal (Q41729564) (← links)
- Pharmacological evaluation of NSAID-induced gastropathy as a "Translatable" model of referred visceral hypersensitivity (Q42013293) (← links)
- Identification of mu- and kappa-opioid receptors as potential targets to regulate parasympathetic, sympathetic, and sensory neurons within rat intracardiac ganglia. (Q42961206) (← links)